Covidien Ltd Launches Optistar™ Elite™ Contrast Delivery System

ST. LOUIS--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Imaging Solutions business is launching the Optistar™ Elite™ contrast delivery system. The product, which recently received U.S. Food and Drug Administration clearance, is designed to inject contrast media-related drugs into a patient’s vascular system to aid in obtaining diagnostic images when used with magnetic resonance (MR) imaging equipment. The new Optistar Elite provides improved performance and ease of use, compared with the previous Optistar LE model.